Brain Tumor Center Clinician Resources

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Pediatric Neuro-Oncology clinical fellowship

Dana-Farber/Boston Children's Cancer and Blood Disorders Center's Pediatric Neuro-Oncology Program offers an intensive one-year clinical training program designed to prepare physicians for a career in pediatric neuro-oncology. Our trainees receive highly specialized, multidisciplinary training at Dana-Farber Cancer Institute and Boston Children’s Hospital. 

Clinical highlights

Dana Farber/Boston Children’s is home to New England’s most active pediatric neuro-oncology clinical research program, which provides access to unique clinical trials for patients with newly diagnosed, relapsed or refractory brain tumors.

We are New England’s Phase I Children’s Oncology Group referral center, a Pediatric Oncology Experimental Therapeutics Investigator Consortium (POETIC) member and a member of the Department of Defense Neurofibromatosis Clinical Trial Consortium. We are also members of the Pediatric Blood and Marrow Transplant Consortium (PBMTC).

We have a dedicated pediatric neuro-oncology service for chemotherapy administration and other inpatient hospitalizations on a dedicated clinical Neurosciences floor at Children’s with specialized staff and nurses.

  • Our outpatient clinic sees more than 2,000 visits per year.

  • We care for an average of 125 new patients each year.

  • We follow more than 1,000 pediatric brain tumor survivors in our Outcomes Program.

We are skilled at improving current therapeutic approaches and outcomes of hard-to-treat pediatric brain tumors, such as atypical teratoid rhabdoid tumor (AT/RT), low-grade astrocytoma (LGA), high-grade astrocytomas (HGA), diffuse intrinsic pontine glioma and medulloblastoma.

Graduates from the Pediatric Neuro-Oncology Fellowship program, which was established in 2001, have secured faculty positions at Dana-Farber/Boston Children's (Boston, MA), Royal Children’s Hospital (Melbourne, Australia), Children’s Hospital of Los Angeles (Los Angeles, CA), Hasbro Children’s Hospital (Providence, RI), and Memorial Sloan-Kettering Cancer Center (New York, NY), among others.
 

Responsibilities

The Pediatric Neuro-Oncology Fellow will:

  • work under the supervision of the pediatric neuro-oncology staff to diagnose, treat, and provide long-term follow-up for children with diverse CNS tumors on both the inpatient and outpatient services.

  • be expected to develop a clinical research interest and complete a clinical research project during the course of the training program.

  • obtain training in several areas related to neuro-oncology, such as neurosurgery, neuropathology, neuroradiology, nuclear medicine, radiation oncology and neuropsychology.

  • be responsible for supervising first-year General Pediatric Hematology/Oncology fellows.

  • gain experience in Phase I and II clinical trials

  • During the fellowship year, the fellow will be appointed as Instructor at Harvard Medical School and receive attending physician status and privileges.


Fellowship schedule and prerequisites

The Fellowship runs from July 1 through June 30 of each academic year. Applicants must:

  • have completed a ACGME-accredited General Pediatrics residency and Pediatric Hematology/Oncology fellowship,

  • have Board-certification in General Pediatrics, and

  • be Board-certified/eligible in Pediatric Hematology/Oncology

  • Applications for fellowship are accepted on a rolling basis. All candidates are encouraged to apply.


Program leadership

All members of the teaching staff are faculty at Dana-Farber Cancer Institute, Boston Children’s Hospital and Harvard Medical School.

  • Mark Kieran, MD, PhD
    Director, Pediatric Medical Neuro-Oncology, Dana-Farber Cancer Institute and Boston Children’s Hospital
    Associate Professor in Pediatrics, Harvard Medical School

  • Susan Chi, MD
    Director, Pediatric Brain Tumor Clinical Trials Program, Dana-Farber Cancer Institute and Boston Children’s Hospital
    assistant professor in Pediatrics, Harvard Medical School

  • Peter Manley, MD
    Director, Pediatric Neuro-Oncology Outcomes Clinic, Dana-Farber Cancer Institute and Boston Children’s Hospital
    Instructor in Pediatrics, Harvard Medical School

  • Nathan Robison, MD
    Director of Pediatric Brain Tumor Clinical Care, Dana-Farber Cancer Institute and Boston Children’s Hospital Instructor in Pediatrics, Harvard Medical School


Applications and inquires

Please contact:

Susan Chi, MD
Dana-Farber/Boston Children's Hospital Cancer Center
Pediatric Neuro-Oncology Fellowship Program
44 Binney Street, Rm SW331
Boston, MA 02115

Phone: 617- 632-4386
Fax: 617-632-4897 
Email: susan_chi@dfci.harvard.edu

Alternate Program Contact: eloise_adamson@dfci.harvard.edu

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
close
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
More optionsSearch
Condition & Treatments
Search for a Condition or Treatment:
Show Items Starting With: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
View allSearch
Visitor Information

Contact the Brain Tumor Center

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close